Pharma Market Access Insights - from Petauri Evidence

Designing a Global Market Access Strategy Built for MFN

Send us Fan Mail How will Most Favored Nation (MFN) pricing reshape global pharmaceutical strategy? What do emerging Centers for Medicare & Medicaid Service (CMS) models

LATAM Market Access Unlocked: Insights from Argentina, Brazil, Colombia, and Mexico

Send us Fan Mail How do LATAM healthcare markets differ and what do these differences mean for Pharma and Medtech launch planning? What should global market access teams

The Evolving NHS – An ICS Chief Pharmacist’s Perspective

Send us Fan Mail What does the evolving NHS landscape look like through the eyes of a Chief Pharmacist, and how are integrated care system (ICS) pharmacy teams respondin

First to Market: Unlocking Switzerland’s Pharma Potential

Send us Fan Mail What makes Switzerland a compelling first-launch market for Pharma? How does its healthcare system compare to other European countries? What do manufact

Q&A Webinar: The Evolving NHS Landscape in England – From Policy to Practice

Send us Fan Mail In this NHS Whispers live Q&A webinar, Katie Mulholland (Senior Consultant, UK Market Access, Petauri Evidence) speaks to:  - Sarah Everest Ford (Progra

Global Pricing and Market Access – Strategies for Success in an Evolving Landscape

Send us Fan Mail Uncover the forces driving change in global pricing and access In this expert-led discussion we explore the latest trends, challenges, and strategic con

Transforming Global Market Access: Smarter Resource Management with Local Affiliates

Send us Fan Mail Discover a smarter way to manage and share market access resources with local affiliates Are your global market access resources scattered, leading to

Communicating value to US Payers: Insights for Pharma and Medtech

Send us Fan Mail What do global market access teams need to know about the US market? What do US payers expect to hear from Pharma and Medtech companies? What kind of va

Navigating market access: Launch strategies and health economic modelling for medical devices

Send us Fan Mail Discover how health economics can support successful Medical Device launch, proposition development, and market access This episode offers an insightfu

Navigating US payer evidence needs to optimise market access

Send us Fan Mail What clinical and economic evidence do US payers prefer to drive formulary decisions? How can you optimise your chances of preferential access in the US

Best practice RWE approaches to support economic modelling for HTA

Send us Fan Mail How can real-world evidence (RWE) support health technology assessment (HTA)? Can real-world data (RWD) supplement clinical data? How can RWE be used to

NHS winter planning 2024–25 – Engaging with NHS decision-makers through Autumn to Christmas

Send us Fan Mail How is the NHS preparing for winter? Which challenges are the most pressing for NHS decision-makers? How can industry best engage and support NHS decisi

De-mystifying the NHS – What you need to know about the NHS as a market for your health technology

Send us Fan Mail Are you a global market access lead looking to understand the challenges faced by your UK affiliates? Or do you work at a national level with responsibi

NHS primary care panel – the GP Contract and Operational Planning Guidance

Send us Fan Mail What can we expect to see in primary care in the NHS given recent policy announcements and ongoing uncertainty? What does the new GP Contract tell us ab

Engage NHS healthcare decision-makers with RWD

Send us Fan Mail Discover how data visualisation dashboards can aid field teams in market access discussions with customers. Healthcare leaders look to real-world data

Market access and reimbursement in Canada – changes at CADTH

Send us Fan Mail What do you need to know about the market access and reimbursement landscape in Canada? What changes can we expect at the Canadian Agency for Drugs and

Rare Disease market access in the MENA and Nordic regions

Send us Fan Mail Where will you be launching your new orphan medicine? You may be confident that your Global market access strategy will support access in key launch mar

How does funding flow in NHSE Regions?

Send us Fan Mail Which decisions are made at Region level in the NHS in England? How do finances and funding work at this level? And how can industry best support and en

NHS policy for 2024/25: strategy and engagement in a world of uncertainty (recorded in Jan 2024)

Send us Fan Mail What do we know about plans and policy for 2024/25? As the expected central operating plan had not materialised (at time of recording), and with a gener

De-mystifying health economic model classifications and structures

Send us Fan Mail What is health economic evaluation and which modelling approaches can be used to support market access activities? In this episode, our expert health e